Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Spiekermann

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
MMW Fortschritte Der Medizin|March 20, 2026
[Recognizing, classifying, and treating thrombocytopenia]Michael Völkl, Karsten Spiekermann, Michael von Bergwelt-Baildon
Experimental Hematology|July 24, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cellsKarsten Spiekermann, Florian Faber, Robert Voswinckel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 7, 2025
[Immunosuppression in Cancer: Strategies for Infection Prevention]Charlotte Schwicht, Michael von Bergwelt-Baildon, Karsten Spiekermann
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[Infections in patients with acute myeloid leukemia]Sabine Ehrlich, Karsten Spiekermann, Jan Hendrik Grothe, et al.
Experimental Hematology & Oncology|September 7, 2013
Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617FFriederike Pastore, Stephanie Schneider, Oliver Christ, et al.
Experimental Hematology|November 7, 2012
Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinasesHarald Polzer, Hanna Janke, Diana Schmid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cellsKarsten Spiekermann, Ksenia Bagrintseva, Ruth Schwab, et al.
Deutsche Medizinische Wochenschrift (1946)|August 23, 2023
[Artificial Intelligence for computer-aided leukemia diagnostics]Christian Matek, Carsten Marr, Michael von Bergwelt-Baildon, et al.
Plos One|April 16, 2014
The role of therapeutic leukapheresis in hyperleukocytotic AMLFriederike Pastore, Alessandro Pastore, Georg Wittmann, et al.
Blood|October 18, 2002
A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaKarsten Spiekermann, Ksenia Bagrintseva, Claudia Schoch, et al.
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
MMW Fortschritte Der Medizin|March 20, 2026
[Recognizing, classifying, and treating thrombocytopenia]Michael Völkl, Karsten Spiekermann, Michael von Bergwelt-Baildon
Experimental Hematology|July 24, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cellsKarsten Spiekermann, Florian Faber, Robert Voswinckel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 7, 2025
[Immunosuppression in Cancer: Strategies for Infection Prevention]Charlotte Schwicht, Michael von Bergwelt-Baildon, Karsten Spiekermann
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[Infections in patients with acute myeloid leukemia]Sabine Ehrlich, Karsten Spiekermann, Jan Hendrik Grothe, et al.
Experimental Hematology & Oncology|September 7, 2013
Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617FFriederike Pastore, Stephanie Schneider, Oliver Christ, et al.
Experimental Hematology|November 7, 2012
Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinasesHarald Polzer, Hanna Janke, Diana Schmid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cellsKarsten Spiekermann, Ksenia Bagrintseva, Ruth Schwab, et al.
Deutsche Medizinische Wochenschrift (1946)|August 23, 2023
[Artificial Intelligence for computer-aided leukemia diagnostics]Christian Matek, Carsten Marr, Michael von Bergwelt-Baildon, et al.
Plos One|April 16, 2014
The role of therapeutic leukapheresis in hyperleukocytotic AMLFriederike Pastore, Alessandro Pastore, Georg Wittmann, et al.
Blood|October 18, 2002
A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaKarsten Spiekermann, Ksenia Bagrintseva, Claudia Schoch, et al.
Pageof 21